切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2007, Vol. 01 ›› Issue (02) : 89 -92. doi: 10.3877/cma.j.issn.1674-0793.2007.02.007

临床试验

肝癌淋巴结转移——外科治疗面临的挑战之一
梅铭惠1, 陈谦1, 杨景红1, 邱维家2, 袁晟光1, 吕军1, 喻亚群1, 翁俊1, 刘杰1   
  1. 1.桂林医学院附属医院肝胆外科附属医院肝胆外科
    2.桂林医学院附属医院肝胆外科附属医院附属医院介入放射科
  • 出版日期:2007-02-01

Lymphonoid metastasis:A challenge to surgical treatments of liver cancer

Ming-hui MEI1, Qian CHEN1, Jing-hong YANG1, Wei-jia QIU1, Sheng-guang Yuan1, Jun Lv1, Ya-qun Yu1, Jun Weng1, Jie Liu1   

  1. 1.Department of Hepato-Biliary Surgery,Affiliated Hospital,Guilin Medical College,541001 Guilin
  • Published:2007-02-01
引用本文:

梅铭惠, 陈谦, 杨景红, 邱维家, 袁晟光, 吕军, 喻亚群, 翁俊, 刘杰. 肝癌淋巴结转移——外科治疗面临的挑战之一[J/OL]. 中华普通外科学文献(电子版), 2007, 01(02): 89-92.

Ming-hui MEI, Qian CHEN, Jing-hong YANG, Wei-jia QIU, Sheng-guang Yuan, Jun Lv, Ya-qun Yu, Jun Weng, Jie Liu. Lymphonoid metastasis:A challenge to surgical treatments of liver cancer[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2007, 01(02): 89-92.

目的

探讨肝癌淋巴转移的相关因素、转移规律、治疗方法,以及对疗效和预后的影响。

方法

分析21例肝癌合并肝外淋巴结转移的病理类型、转移部位、术前术后诊断符合率、手术治疗、术后辅助治疗和生存率。

结果

21例中原发性肝癌19例:肝细胞癌(HCC)12例、胆管细胞癌5例、混合型肝癌2例,转移性肝癌2例。肿瘤位于I段(尾状叶右段),V段,V、VIII段,VII、VIII段和V、VI段各1例,II、III段3例,II-IV段6例,VI、VII段5例,肿瘤侵及全肝2例。肿瘤直径最小4.5cm,最大15cm,平均直径7.5cm。术前诊断肝外淋巴结转移7例(33.4%,7/21),其余均为术中探查所发现,术前漏诊率66.6%(14/21)。肿瘤单侵犯第8组淋巴结10例(47.61%),第8、12组4例(19.04%),累计淋巴侵犯超过3组以上,即7~9组和(或)8、11~13组5例(23.80%),单纯侵犯第13组和14组各1例(9.52%)。此外,同时合并胆囊、肝外胆管、廉状韧带或肝十二指肠韧带脂肪组织转移3例。3组淋巴结以上被侵犯或合并远处淋巴结及组织转移的10例中,HCC 3例,占HCC组的25%(3/12);胆管细胞癌3例,占该组的60%(3/5);混合型肝癌、转移性肝癌各2例,100%(4/4)。2例HCC术后肝内或远处淋巴转移再次手术。21例术后平均生存时间7.8月,最短3个月,最长34个月。5例存活超过12个月的患者术后均接受了TACE或肝脏局部化疗。

结论

肝癌淋巴结侵犯以第8组淋巴结受累的几率最高,达91%(19/21),而淋巴结转移的严重程度与肝癌的病理类型有关。由于术前漏诊率较高,应重视术前临床资料的分析和术中的仔细探查,尤其是第8组淋巴结。转移淋巴结的清扫和术后综合治疗对改善此类患者的预后有积极意义。淋巴结的清除相对肝癌的切除更困难,熟练掌握肝门淋巴外科的技术和要点是关键。

Objective

To investigate the related factors that effect on lymphonoid metastasis of liver cancer,pathway of lymphatic invasion,surgical procedures,postoperative adjuvant therapies and the prognosis of patients.

Methods

21 cases of liver cancer with lymphonoid metastasis were analyzed in this study,including the pathology of tumor,tumor invasion of regional lymph nodes,accordant rates of pre-and postoperative diagnosis,treatments,postoperative therapies and survival of the patients.

Results

The pathological diagnosis of liver cancer included:HCC in 12,cholangiocellular carcinoma in 5,mixed hepatoma and secondary liver cancer in 2 respectively.Liver tumor located in segment I,V,ⅤandⅧ,ⅤandⅥ,ⅦandⅧin 1 case respectively,segment II andⅢin 3,segmentⅡ-Ⅳin 6,VI andⅦin 5 and diffuse invasion in 2 cases.The average diameter of the tumor was 7.5 cm.Lymphonoid invasion was diagnosed preoperatively in 7 patients(33.4%),and the rest were diagnosed intraoperation(66.6%).The group 8 of lymph node was involved in 10 cases(47.6%),group 8 and 12 in 4(19%),more than 3 groups were invaded in 5(23.8%),and distal group 13 or 14 was singly involved in 1 respectively(9%).In addition,there were 3 cases of the 21 patients with tumor metastasis to gall bladder,extrahepatic bile duct and other tissues.In the 10 patients with more than 3 groups lymph nodes invasion or distal lymphatic and other tissue metastasis,3 were HCC(3/12),accounting for 25%of the HCC cases,3 were cholangiocellular carcinoma(3/5,60%),mixed liver caner and secondary liver cancer were 2 respectively(4/4,100%).Two cases of HCC were reoperated on due to tumor recurrence.The mean survival of the 21patients was 7.8 months,shortest 3months and longest 34 months.5 cases receiving postoperative chemotherapies survived more than 12 months.

Conclusion

It has been suggested from our study that the most prevalent invasion of lymph node in liver cancer is the group 8,about 91%(19/21).The severity of lymphatic involvement is related to the pathological pattern of the tumor.As the relatively high missdiagnostic rate preoperation,it should be emphasized that careful preoperative assessment of clinical data and intraoperative exploration(especially the lymph node of group 8)are needed.Resection of the implicated lymph nodes and postoperative adjuvant therapies will be of benefit for the patients to improve the prognosis.Because it is rather difficult to remove the involved lymph nodes,it is necessary for a surgeon to master the essential technique of lymphatic resection.

1
黄志强.肝胆胰区的淋巴外科.见:黄志强,黄晓强主编.肝胆胰外科聚焦.第一版.北京:人民军医出版社,2005.515~521
2
Blumgart L H.Hann L E.Surgical and radiologic anatomy of the liver and biliary tract.In:Blumgart L.H.Fong Y,Surgery of the liver and biliary tract.3rd ed.NY.W.B Saunders Company,2002,3~33
3
徐光伟,胃肿瘤.见:吴阶平,裘法祖,主编.黄家驷外科学.第六版.北京:人民卫生出版社,1999,1031~1052
4
梅铭惠.肝门部外科解剖技巧与要点.广西科学,1997,4:61~63
5
徐静,梅铭惠,陈谦等.术中组织间植入125I粒子治疗肝恶性肿瘤.中华实验外科杂志,2005,22:368~369
6
谢娜,闵鹏秋,陈卫霞,等.肝细胞癌累及门腔间隙CT、MRI特征探讨.临床放射学杂志,2005,24:328~332
7
梅铭惠,陈谦,杨景红,等.肝动脉外科解剖在肝动脉置管术中的应用及意义.中华实验外科杂志,2003,20:1142~1144
8
瞿佐发.腹部的淋巴管和淋巴结.见:瞿佐发主编.系统解剖学.第一版.北京:人民卫生出版社,2005,214~228
9
徐静,梅铭惠,陈谦,等.端冷射频治疗肝癌的临床及病理学研究.华中医学杂志,2003,27:83~84
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 王佳佳, 詹韵韵, 姜凡, 孙碧云, 毕玉, 李如冰, 彭梅. Peyton四步教学法在超声住院医师规范化培训颈部淋巴结分区中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 814-818.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[5] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[6] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[7] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[8] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[9] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
[10] 韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
[11] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[12] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[13] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[14] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[15] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
阅读次数
全文


摘要